CI Canadian Convertible Bond ETF Common (CXF) Competitors C$10.30 -0.07 (-0.68%) As of 08/8/2025 03:56 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesBuy This Stock CXF vs. IPA, CRDL, APM, GXE, GPH, WMD, EQ, SGW, MDNA, and CGCShould you be buying CI Canadian Convertible Bond ETF Common stock or one of its competitors? The main competitors of CI Canadian Convertible Bond ETF Common include ImmunoPrecise Antibodies (IPA), Cardiol Therapeutics (CRDL), Andean Precious Metals (APM), Gear Energy (GXE), Graphite One (GPH), WeedMD (WMD), EQ (EQ), Shoal Games (SGW), Medicenna Therapeutics (MDNA), and Canadian Gold (CGC). These companies are all part of the "pharmaceutical products" industry. CI Canadian Convertible Bond ETF Common vs. Its Competitors ImmunoPrecise Antibodies Cardiol Therapeutics Andean Precious Metals Gear Energy Graphite One WeedMD EQ Shoal Games Medicenna Therapeutics Canadian Gold CI Canadian Convertible Bond ETF Common (TSE:CXF) and ImmunoPrecise Antibodies (CVE:IPA) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership. Does the media refer more to CXF or IPA? In the previous week, ImmunoPrecise Antibodies' average media sentiment score of 0.40 beat CI Canadian Convertible Bond ETF Common's score of 0.00 indicating that ImmunoPrecise Antibodies is being referred to more favorably in the news media. Company Overall Sentiment CI Canadian Convertible Bond ETF Common Neutral ImmunoPrecise Antibodies Neutral Is CXF or IPA more profitable? Company Net Margins Return on Equity Return on Assets CI Canadian Convertible Bond ETF CommonN/A N/A N/A ImmunoPrecise Antibodies N/A N/A N/A Which has preferable earnings & valuation, CXF or IPA? CI Canadian Convertible Bond ETF Common has higher earnings, but lower revenue than ImmunoPrecise Antibodies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCI Canadian Convertible Bond ETF CommonN/AN/AN/AN/AN/AImmunoPrecise AntibodiesC$19.47M8.33-C$22.19M-C$0.89-7.30 SummaryImmunoPrecise Antibodies beats CI Canadian Convertible Bond ETF Common on 2 of the 2 factors compared between the two stocks. Get CI Canadian Convertible Bond ETF Common News Delivered to You Automatically Sign up to receive the latest news and ratings for CXF and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CXF vs. The Competition Export to ExcelMetricCI Canadian Convertible Bond ETF CommonPharmaceutical Preparations IndustryManufacturing SectorTSE ExchangeMarket CapC$52.07MC$857.25MC$2.54BC$6.34BDividend Yield4.84%4.84%2.57%6.72%P/E RatioN/A1.1422.2162.43Price / SalesN/A26.6685.221,654.03Price / CashN/A19.5623.8983.29Price / BookN/A6.5437.734.90Net IncomeN/A-C$4.07MC$31.01MC$301.20M7 Day Performance-0.58%121.77%1.55%1.84%1 Month Performance-0.77%1.87%1.15%1.27%1 Year PerformanceN/A22.82%28.08%30.40% CI Canadian Convertible Bond ETF Common Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CXFCI Canadian Convertible Bond ETF CommonN/AC$10.30-0.7%N/A+4.3%C$52.07MN/A0.0090IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownCRDLCardiol TherapeuticsN/AC$1.91-7.3%N/A-49.5%C$158.49MN/A-3.7520News CoverageAPMAndean Precious Metals2.3901 of 5 starsC$1.29+7.5%C$2.00+55.0%+40.2%C$135.47MC$154.78M2.5530GXEGear EnergyN/AN/AN/AN/AC$126.52MC$134.93M10.391,310GPHGraphite OneN/AC$1.07+17.6%N/A+27.5%C$108.34MN/A-15.3920High Trading VolumeWMDWeedMDN/AC$0.28-1.8%N/A+0.0%C$67.82MC$27.53M-0.66628Gap UpEQEQN/AC$0.97flatN/A-15.7%C$67.51MC$9.70M-14.4840News CoverageGap DownSGWShoal GamesN/AC$0.50+42.9%N/A+0.0%C$65.56MC$106.98K-12.5040Gap UpMDNAMedicenna TherapeuticsN/AC$0.84flatN/A-45.9%C$62.85MC$4.87K-2.3120News CoverageCGCCanadian GoldN/AC$0.30flatN/A+87.5%C$54.68MC$36.51M-9.833,150High Trading Volume Related Companies and Tools Related Companies IPA Alternatives CRDL Alternatives APM Alternatives GXE Alternatives GPH Alternatives WMD Alternatives EQ Alternatives SGW Alternatives MDNA Alternatives CGC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:CXF) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CI Canadian Convertible Bond ETF Common Please log in to your account or sign up in order to add this asset to your watchlist. Share CI Canadian Convertible Bond ETF Common With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
